Lu-DOTATATE 在慢性淋巴细胞白血病中持久细胞减灭术的首次经验。
First experience of durable cytoreduction in chronic lymphoid leukemia with Lu-DOTATATE.
机构信息
Nuclear Medicine Department and Molecular Imaging, CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland.
Medical Oncology, Clinique Bois-Cerf, Lausanne, Switzerland.
出版信息
Med Oncol. 2019 Mar 27;36(5):41. doi: 10.1007/s12032-019-1266-0.
PMID:30919094
Abstract
This is the first described case of effective and durable cytoreduction after PRRT with Lu-DOTATATE in a 75-year-old female, with B cell chronic lymphoid leukemia, and well-differentiated metastatic neuroendocrine tumor.
摘要
这是首例在患有 B 细胞慢性淋巴细胞白血病和分化良好的转移性神经内分泌肿瘤的 75 岁女性中，使用 Lu-DOTATATE 进行 PRRT 后有效且持久的细胞减灭术的描述性病例。
Zotero 插件